Terms: = Pancreatic cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
18 results:
1. Nuclear PLD1 combined with npm1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
[TBL] [Abstract] [Full Text] [Related]
2. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
Zhu Q; He P; Zheng C; Chen Z; Qi S; Zhou D; Li Y; Ouyang Q; Zi H; Tang H; Xing J; Xie Y; Zhu S; Ren J; Huang J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8369-8378. PubMed ID: 37079049
[TBL] [Abstract] [Full Text] [Related]
3. Immortalization-upregulated protein promotes pancreatic cancer progression by regulating npm1/FHL1-mediated cell-cycle-checkpoint protein activity.
Luo Q; Pan Y; Fu Q; Zhang X; Zhou S; Yu P; Tian H; Liu P; Chen S; Zhang H; Qin T
Cell Biol Toxicol; 2023 Oct; 39(5):2069-2087. PubMed ID: 35142956
[TBL] [Abstract] [Full Text] [Related]
4. Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation.
Liang J; Li G; Liao J; Huang Z; Wen J; Wang Y; Chen Z; Cai G; Xu W; Ding Z; Liang H; Datta PK; Chu L; Chen X; Zhang B
Cell Death Differ; 2022 May; 29(5):988-1003. PubMed ID: 35034103
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma.
Zhao X; Li H; Lyu S; Zhai J; Ji Z; Zhang Z; Zhang X; Liu Z; Wang H; Xu J; Fan H; Kou J; Li L; Lang R; He Q
Int J Biol Sci; 2021; 17(10):2590-2605. PubMed ID: 34326696
[TBL] [Abstract] [Full Text] [Related]
6. PRMT1 promotes the tumor suppressor function of p14
Repenning A; Happel D; Bouchard C; Meixner M; Verel-Yilmaz Y; Raifer H; Holembowski L; Krause E; Kremmer E; Feederle R; Keber CU; Lohoff M; Slater EP; Bartsch DK; Bauer UM
EMBO J; 2021 Jul; 40(13):e106777. PubMed ID: 33999432
[TBL] [Abstract] [Full Text] [Related]
7. Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer.
Lee HS; Kim E; Lee J; Park SJ; Hwang HK; Park CH; Jo SY; Kang CM; Hong SM; Kang H; Jo JH; Cho IR; Chung MJ; Park JY; Park SW; Song SY; Han JM; Kim S; Bang S
EBioMedicine; 2021 Mar; 65():103218. PubMed ID: 33639403
[TBL] [Abstract] [Full Text] [Related]
8. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
9. Relocation of npm Affects the Malignant Phenotypes of Hepatoma SMMC-7721 Cells.
Li X; Xu DH; Liu F; Liu GY; Lu K; Deng XL; Li QF; Shi SL
J Cell Biochem; 2017 Oct; 118(10):3225-3236. PubMed ID: 28262969
[TBL] [Abstract] [Full Text] [Related]
10. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
[TBL] [Abstract] [Full Text] [Related]
11. Somatic mosaic mutations of IDH1 and npm1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.
Akiyama M; Yamaoka M; Mikami-Terao Y; Ohyama W; Yokoi K; Arakawa Y; Takita J; Suzuki H; Yamada H
Int J Hematol; 2015 Dec; 102(6):723-8. PubMed ID: 26508204
[TBL] [Abstract] [Full Text] [Related]
12. npm1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells.
Zhu Y; Shi M; Chen H; Gu J; Zhang J; Shen B; Deng X; Xie J; Zhan X; Peng C
Oncotarget; 2015 Aug; 6(25):21443-51. PubMed ID: 26068981
[TBL] [Abstract] [Full Text] [Related]
13. AKT regulates npm dependent ARF localization and p53mut stability in tumors.
Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
[TBL] [Abstract] [Full Text] [Related]
14. Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.
Xu DH; Liu F; Li X; Chen XF; Jing GJ; Wu FY; Shi SL; Li QF
Int J Oncol; 2014 Jul; 45(1):264-72. PubMed ID: 24787960
[TBL] [Abstract] [Full Text] [Related]
15. Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells.
Bhat UG; Jagadeeswaran R; Halasi M; Gartel AL
J Biol Chem; 2011 Dec; 286(48):41425-41433. PubMed ID: 21979956
[TBL] [Abstract] [Full Text] [Related]
16. Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin.
Zhao D; Xu D; Zhang X; Wang L; Tan W; Guo Y; Yu D; Li H; Zhao P; Lin D
Gastroenterology; 2009 May; 136(5):1659-68. PubMed ID: 19422084
[TBL] [Abstract] [Full Text] [Related]
17. Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.
Rizos H; McKenzie HA; Ayub AL; Woodruff S; Becker TM; Scurr LL; Stahl J; Kefford RF
J Biol Chem; 2006 Dec; 281(49):38080-8. PubMed ID: 17035234
[TBL] [Abstract] [Full Text] [Related]
18. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract] [Full Text] [Related]
